Cyprotex (CRX)

 

Latest News

Form 8.5 (EPT/RI) - Cyprotex Plc

RNS Number: 3273L Nplus1 Singer Capital Markets Ltd 30 September 2016 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of exempt p...

Form 8.5 (EPT/RI) - Cyprotex Plc

RNS Number: 1987L Nplus1 Singer Capital Markets Ltd 29 September 2016 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of exempt p...

Form 8.5 (EPT/RI) - Cyprotex Plc

RNS Number: 9275K Nplus1 Singer Capital Markets Ltd 27 September 2016 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of exempt p...

Form 8.3 - Cyprotex Plc

RNS Number: 8022K Charles Stanley & Co. Ltd. 26 September 2016 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: STOCKINVEST L...

All News

DateHeadlineSource
30-09-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
29-09-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
27-09-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
26-09-16Form 8.3 - Cyprotex PlcRNS
26-09-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
26-09-16Cyprotex appoints director of US operations StockMarketWire
26-09-16Appointment of new Director of US OperationsRNS
23-09-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
21-09-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
20-09-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
19-09-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
16-09-16Form 8.3 - Cyprotex plcRNS
16-09-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
15-09-16Form 8.3 - Cyprotex plcRNS
15-09-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
13-09-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
13-09-16Extension of metabolite identification serviceRNS
12-09-16Form 8.3 - Cyprotex plcRNS
09-09-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
08-09-16Cyprotex expands ADME capabilitiesStockMarketWire
08-09-16Expansion ADME capabilities (8 transporter assays)RNS
07-09-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
06-09-16Form 8.5 (EPT/RI) - Cyprotex PLCRNS
02-09-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
01-09-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
31-08-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
30-08-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
26-08-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
25-08-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
25-08-16Installation of two mass spectrometer systemsRNS
23-08-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
22-08-16Form 8.5 (EPT/RI)RNS
17-08-16Form 8.3 - Cyptotex PlcRNS
17-08-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
16-08-16Form 8.5 (EPT/RI) - Cyprotex PLCRNS
15-08-16Form 8.3 - Cyprotex PlcRNS
15-08-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
12-08-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
11-08-16Form 8.5 (EPT/RI) - Cyprotex PlcRNS
10-08-16Form 8.3 - Cyprotex PlcRNS

RSS feeds

  • Editorial news feed for LSE:CRX Editorial
  • Regulatory news feed for LSE:CRX Regulatory